RFL

Rafael Holdings, Inc. (RFL) PESTLE Analysis Analysis (2026)

Invetso Score: 5.5/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Political

Score: 5.8 (Moderate)

Rafael Holdings faces a moderately complex political environment, balancing U.S. regulatory dynamics, evolving board leadership, and indirect geopolitical exposure. While governance enhancements may strengthen oversight, sector and regional risks remain material.

Economic

Score:

Rafael Holdings’ economic position is structurally weak, with limited scale, negative cash flows, and high reliance on external capital. While recent fundraising improves liquidity, sustainable growth depends on successful clinical milestones and future capital access.

Social

Score:

Rafael Holdings benefits from a socially impactful mission and engaged stakeholders, but leadership transitions and the challenges of rare disease drug development present ongoing social risks.

Technological

Score:

Rafael Holdings’ technological position is moderate, with progress in its lead program but high concentration risk and limited pipeline breadth. Success depends on clinical trial outcomes and future innovation.

Legal

Score:

Rafael Holdings faces typical legal risks for a clinical-stage biotech, including regulatory compliance and IP protection. Recent governance enhancements may improve oversight, but legal risks remain material until commercialization.

Environmental

Score:

While Rafael Holdings’ direct environmental risks are low, indirect exposure through investments and limited ESG disclosure may present future challenges as sustainability standards rise.

Overall Score

Score:

Rafael Holdings is positioned as a small, clinical-stage biotech with moderate risk across most PESTLE dimensions. The company’s strengths include a focused rare disease program, recent liquidity improvements, and enhanced governance. However, it faces persistent economic and technological concentration risks, limited scale, and indirect exposure to geopolitical and environmental factors. Sustainable value creation will depend on clinical success, capital access, and effective risk management.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Rafael Holdings, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →

Invetso is not affiliated with or regulated by the U.S. Securities and Exchange Commission (SEC), the Financial Industry Regulatory Authority (FINRA), or any other financial regulatory authority. The analyses, scores and all the information provided by Invetso are strictly for informational purposes only and do not constitute financial advice, recommendations, or an offer to buy or sell any securities. Invetso is not a registered financial advisor, broker-dealer, or investment advisor, and it does not provide personalized investment, legal, or tax advice. The content provided on this website is not intended to serve as a substitute for professional advice. Users should conduct their own research and consult with a qualified financial advisor before making any investment decisions. All analysis, data, and information presented on this site are based on publicly available information and should be used at the user’s own risk. Invetso does not guarantee the accuracy, completeness, or timeliness of any information or data provided, nor does it endorse any specific securities, companies, or strategies. Any reliance you place on such information is strictly at your own risk. While we strive to provide accurate and up-to-date information, Invetso makes no warranties or representations regarding the completeness, accuracy, or reliability of any analyses or data on our platform, and any such information is subject to the terms and conditions of the Invetso Terms of Service. Our analyses are generated using AI technologies and AI-generated content may contain errors or inaccuracies. Use the information at your own risk. Our platform may contain links to third-party websites, for which we are not responsible for the content or accuracy of information. Invetso shall not be liable for any loss or damage arising from the use of our services. By using this website, you agree that Invetso is not responsible for any losses, damages, or financial outcomes that may result from your use of the information, tools, or resources provided. We recommend consulting with a licensed financial professional before making any investment decisions.

For more details, please refer to our Terms of Service and Privacy Policy.